Eurofins Strengthens Its Asia Pacific Footprint with the Acquisition of the NM Group of Laboratories in Malaysia
November 30 2015 - 10:31AM
Business Wire
Regulatory News:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), the global leader in food and
environment testing services, announces that it has acquired the NM
Group of Laboratories (NML), one of the leading private
laboratories in Malaysia for food and environment testing.
NML employs about 120 staff across its 3 facilities,
strategically located in the northern and southern parts of the
country. Established in 1980 originally for testing of dried
rubber, NML has developed into one of the leading private
laboratories providing comprehensive analytical services for food
and environment testing, as well as for rubber testing.
Malaysia has a well-developed market for environment testing,
especially in water and soil contamination given its status as one
of the top exporters of liquefied natural gas (LNG)1. Furthermore,
with the third highest GDP per capita2 in the ASEAN3 region,
sustained consumption growth also supports positive outlook for
testing in food and other consumer products. The acquisition
therefore provides Eurofins entry into this attractive testing
market, a strong platform to roll-out a broader service offering,
and reinforces the Group’s growing footprint in the region. In
return, NML will gain access to the complete infrastructure and
capability of the Group, which should allow substantial expansion
of the range of services it offers to both domestic and
international customers, thereby accelerating its market share
expansion.
Comment from Dr. Gilles Martin, Eurofins CEO: “NML
provides Eurofins a good entry into the analytical testing market
in Malaysia and reinforces our footprint in this rapidly-growing
region. We are looking forward to contributing to strengthening
NML’s position in its market, as well as expanding the portfolio of
tests it makes available to the Malaysian government and industries
by offering the full range of services and capabilities of the
Eurofins Group through NML.”
Notes for the editor:
Eurofins – a global leader in bio-analysis
Eurofins Scientific is the world leader in food, environment and
pharmaceutical products testing. It is also one of the global
market leaders in agroscience, genomics, discovery pharmacology and
central laboratory services. In addition, Eurofins is one of the
key emerging players in specialty clinical diagnostic testing in
Europe and the USA.
With 20,000 staff in around 200 laboratories across 38
countries, Eurofins offers a portfolio of over 130,000 reliable
analytical methods for evaluating the safety, identity,
composition, authenticity, origin and purity of biological
substances and products, as well as for innovative clinical
diagnostic. The Group provides its customers with high-quality
services, accurate results on time and expert advice by its highly
qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities around the
world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
1
http://www.statista.com/statistics/274528/major-exporting-countries-of-lng/2
https://en.wikipedia.org/wiki/List_of_ASEAN_countries_by_GDP_(nominal)3
Association of South East Asian Nations
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151130005922/en/
For more information, please visit
www.eurofins.com or contact:Eurofins Investor
RelationsPhone: +32-2-766 1620E-mail: ir@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Jul 2023 to Jul 2024